Literature DB >> 18771951

Acquisition and spread of Acinetobacter baumannii and Stenotrophomonas maltophilia in intensive care patients.

Martina Barchitta1, Rosalba Cipresso, Loredana Giaquinta, Maria Antonietta Romeo, Carmelo Denaro, Carlo Pennisi, Antonella Agodi.   

Abstract

Acinetobacter baumannii and Stenotrophomonas maltophilia are increasingly important pathogens, especially in the intensive care units (ICUs). This study was designed to investigate the clonality, the mode of transmission and the patients' risk profile for acquisition of A. baumannii and S. maltophilia at the ICU of an Italian Hospital. Patterns of A. baumannii and S. maltophilia acquisition in the ICU during the period of the survey were carriage, colonization and infection. Characterization of A. baumannii was performed by ARDRA and genotyping of both pathogens by PFGE. Our study provided evidence for the occurrence of an outbreak sustained by the two organisms in study involving 27.3% of patients enrolled into the surveillance. The spread of a unique A. baumannii epidemic clone was demonstrated. A major clone of S. maltophilia was responsible for the epidemic spread of S. maltophilia (55.5% of isolates), thus confirming A. baumannii cross-transmission and showing--among few published reports--the clonal spread of S. maltophilia. Outliers analysis suggested colonized patients as the probable epidemic sources. Mechanical ventilation was confirmed as risk factor for infection (OR 8.4; 95%C.I.: 2.6-27.5). A multimodal intervention program was introduced, followed in later months with a drastic restriction of infection and colonization due to A. baumannii and S. maltophilia and subsequently with the successful control of the outbreak. Active surveillance of infection and colonization by high-risk clones, together with implementation of control strategies, including strict hand hygiene, proved to be effective to reduce the epidemic spread of both alert pathogens in our ICU.

Entities:  

Mesh:

Year:  2008        PMID: 18771951     DOI: 10.1016/j.ijheh.2008.07.001

Source DB:  PubMed          Journal:  Int J Hyg Environ Health        ISSN: 1438-4639            Impact factor:   5.840


  11 in total

Review 1.  Stenotrophomonas maltophilia: Significant contemporary hospital pathogen - review.

Authors:  O Nyc; J Matejková
Journal:  Folia Microbiol (Praha)       Date:  2010-06-06       Impact factor: 2.099

2.  Stenotrophomonas maltophilia in the respiratory tract of medical intensive care unit patients.

Authors:  B Saugel; K Eschermann; R Hoffmann; A Hapfelmeier; C Schultheiss; V Phillip; F Eyer; K-L Laugwitz; R M Schmid; W Huber
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-07       Impact factor: 3.267

3.  Stenotrophomonas maltophilia infection among young children in a cardiac intensive care unit: a single institution experience.

Authors:  Ciji Arthur; Xinyu Tang; Jose R Romero; Jeffrey G Gossett; Nada Harik; Parthak Prodhan
Journal:  Pediatr Cardiol       Date:  2014-10-08       Impact factor: 1.655

4.  A review of 11 years of Stenotrophomonas maltophilia blood isolates at a tertiary care institute in Canada.

Authors:  Prenilla Naidu; Stephanie Smith
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

Review 5.  Community-acquired Stenotrophomonas maltophilia infections: a systematic review.

Authors:  M E Falagas; A C Kastoris; E K Vouloumanou; G Dimopoulos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-02-18       Impact factor: 3.267

6.  First multicenter study on multidrug resistant bacteria carriage in Chinese ICUs.

Authors:  Xiaojun Ma; Yinghong Wu; Liuyi Li; Qian Xu; Bijie Hu; Yuxing Ni; Anhua Wu; Shumei Sun; Vincent Jarlier; Jérôme Robert
Journal:  BMC Infect Dis       Date:  2015-08-21       Impact factor: 3.090

7.  Preventable proportion of intubation-associated pneumonia: Role of adherence to a care bundle.

Authors:  Antonella Agodi; Martina Barchitta; Annalisa Quattrocchi; Emiliano Spera; Giovanni Gallo; Francesco Auxilia; Silvio Brusaferro; Marcello Mario D'Errico; Maria Teresa Montagna; Cesira Pasquarella; Stefano Tardivo; Ida Mura
Journal:  PLoS One       Date:  2017-09-06       Impact factor: 3.240

8.  Acinetobacter baumannii strains isolated from patients in intensive care units in Goiânia, Brazil: Molecular and drug susceptibility profiles.

Authors:  Suellen Rocha Araújo Castilho; Cássia Silva de Miranda Godoy; Adriana Oliveira Guilarde; Juliana Lamaro Cardoso; Maria Cláudia Porfirio André; Ana Paula Junqueira-Kipnis; André Kipnis
Journal:  PLoS One       Date:  2017-05-05       Impact factor: 3.240

9.  Antibiotic Consumption and Resistance during a 3-Year Period in Sicily, Southern Italy.

Authors:  Martina Barchitta; Annalisa Quattrocchi; Andrea Maugeri; Maria Clara La Rosa; Claudia La Mastra; Laura Sessa; Pasquale Cananzi; Giuseppe Murolo; Alessandro Oteri; Guido Basile; Antonella Agodi
Journal:  Int J Environ Res Public Health       Date:  2019-06-26       Impact factor: 3.390

10.  Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial.

Authors:  Jong Wook Kim; Joowon Chung; Sang-Ho Choi; Hang Jea Jang; Sang-Bum Hong; Chae-Man Lim; Younsuck Koh
Journal:  Crit Care       Date:  2012-02-15       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.